OpenAlex
PricingAboutJobs
Log inGet started
Work

Clinical relevance of anti‐exenatide antibodies: safety, efficacy and cross‐reactivity with long‐term treatment

HTML

Year: 2012
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2012.01561.x
Authors: M. S. Fineman, K. F. Mace, M. Diamant, T. Darsow, B. B. Cirincione, T. K. Booker Porter, L. A. Kinninger, M. E. Trautmann
Institutions: Eli Lilly (United States), Amsterdam UMC Location Vrije Universiteit Amsterdam, American Diabetes Association
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, GLP-1 receptor agonists, antibody cross-reactivity, antibody titers, long-term treatment safety, glycemic control, HbA1c, adverse events, injection site reactions, type 2 diabetes, anti-drug antibodies, exenatide twice daily, exenatide once weekly
SDG: Good health and well-being

Open Access status: closed

Funder: Amylin Pharmaceuticals
OpenAlex ID: W2009288620
FWCI: 9.583
Cites: 35
Cited by: 158
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security